Patenting activity in drugs for renal disease, January 2002 - June 2004

Abstract

were identified, reviewed and put into context with the peer-reviewed literature wherever this seemed appropriate. The analysis indicates that innovation in the major fields of unmet need in kidney therapy (chronic or acute renal failure and renal cancer) proceeds on a broad front, although the potential for patient benefit that is revealed remained incremental.